Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), Pune has developed and validated the indigenous IgG ELISA test ‘COVID KAVACH ELISA’ for antibody detection for COVID-19.
The robust indigenous IgG ELISA test has been named as “COVID KAVACH ELISA” in line with the Make in India initiative in record time.
The IgG ELISA test will play a critical role in surveillance of the proportion of population exposed to SARS-CoV-2 Coronavirus infection.
Scientific team of NIV has successfully isolated the SARS-CoV-2 virus from laboratory confirmed patients in India. This has led to the development of indigenous diagnostics for SARS-CoV-2.
For this purpose, ICMR has partnered with Zydus Cadila for mass-scale production of the ELISA test kits.
After developing the test at ICMR-NIV, the technology has been transferred for mass-scale production to Zydus Cadila, which is an innovation-driven global healthcare company.
